A diabetes, heart failure and kidney disease medication (sotagliflozin) is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and…
On World Parkinson’s Day, a new theory emerges on the disease’s origins and spread
Credit Aarhus University Hospital/University of Rochester Medical Center The nose or the gut? For the past two decades, the scientific community has debated the wellspring of the toxic proteins at…